Presence of human papilloma viruses (HPVs) in prostate tumors suggests countries should encourage universal vaccination against HPV infections. A literature review published by James Lawson and Wendy Glenn from the University of New South Wales in Australia suggests human papilloma viruses (HPVs) may have a causal role in prostate cancer.…...
Prostate cancer is, after skin cancer, the most common cancer among men and the second biggest cancer killer for men in the United States. It’s typically an older man’s cancer with approximately 60 percent diagnoses in men over 65, with the average age being 66. As cancers go, prostate cancer…...
Since 1999, September has been recognized as National Prostate Awareness Month. In this month, health professionals, researchers, survivors and families take special efforts to increase public knowledge, promote screening, increase education and support research. In 2018, it is estimated that nearly 165,000 men in the U.S. will be diagnosed with…...
A recent study concluded a positive correlation between frequent ejaculation and a reduced risk of prostate cancer. Research has suggested this relationship for years, but a 2016 longitudinal cohort study surveyed nearly 32,000 men across several age groups for 18 years. The study, which was the largest sample size to…...
Cancer researchers at the Thomas Jefferson University in Philadelphia have zeroed in on a specific type of gene loss that sets off large-scale genetic changes that could make prostate cancer both resistant to treatment and more likely to spread. The discovery concerns the retinoblastoma (RB) susceptibility gene, the first “gatekeeper…...
Prostate cancer is never thwarted by the politics of avoidance. Over half of men aged 50 and over have already experienced changes to the tissues and cells in their prostate, which is part of the normal aging process. The likelihood of developing prostate cancer increases with age. While only one…...
CLEVELAND, OH — Two studies conducted by the Cleveland Clinic revealed how a testosterone-related genetic abnormality can help predict individual patient responses to specific prostate cancer therapies. The studies, published in the October 12 issue of JAMA Oncology, suggest that men who inherit this variant would benefit from a personalized…...
Free Cancer Screening Guidelines
National Foundation for Cancer Research(NFCR) is a 501(c)(3) tax-exempt nonprofit organization.
Tax ID #: 04-2531031
5515 Security Lane, Suite 1105 Rockville, MD 20852
